Cart
sales@molnova.com
Decoyinine
CAS No. 2004-04-8
Decoyinine( —— )
Catalog No. M33336 CAS No. 2004-04-8
Decoyinine (Decynylene), a selective inhibitor of GMP synthase, is a novel potential microbial insecticide, a secondary metabolite produced by Streptomyces hygroscopicus.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 227 | In Stock |
|
| 2MG | 85 | In Stock |
|
| 5MG | 265 | In Stock |
|
| 10MG | 530 | In Stock |
|
| 25MG | 1260 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDecoyinine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDecoyinine (Decynylene), a selective inhibitor of GMP synthase, is a novel potential microbial insecticide, a secondary metabolite produced by Streptomyces hygroscopicus.
-
DescriptionDecoyinine is a selective inhibitor of GMP synthetase (GMPS).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorcGAS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2004-04-8
-
Formula Weight279.25
-
Molecular FormulaC11H13N5O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (179.05 mM; Ultrasonic (<60°C); H2O : 6.67 mg/mL (23.89 mM; Ultrasonic (<60°C))
-
SMILESNc1ncnc2n(cnc12)[C@]1(CO)OC(=CO)[C@@H](O)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. A Bianchi-Smiraglia, et al. Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell invasion and tumorigenicity. Cell Death Differ. 2015 Nov; 22(11): 1858–1864.?
molnova catalog
related products
-
Artemisinin
Artemisinin is a drug used to treat multi-drug resistant strains of falciparum malaria (as well as increasingly vivax malaria).
-
Biotin-PEG8-amine
Biotin-PEG8-amine is a PROTAC linker belonging to the PEG class and can be used to synthesize PROTAC molecules.
-
Cixutumumab
Cixutumumab (IMC-A12), a humanized monoclonal antibody targeting IGF-1R, exhibits high affinity and inhibits ligand-dependent receptor activation, impeding downstream signaling.
